Business Summary

WuXi PharmaTech Cayman is a holding company. Through its subsidiaries, the Company is engaged in pharmaceutical, biotechnology and medical device research and development outsourcing, with operations in the People's Republic of China and the United States. The Company provides an integrated portfolio of laboratory and manufacturing services throughout the drug and medical device research and development process to the Company's customers, which include pharmaceutical, biotechnology and medical device companies. The Company conducts its operations in two segments: laboratory services and manufacturing services.

Data provided by Mergent, Inc.

Recent Company News

Powered by Interactive Data Managed Solutions

Capital Raising Events

DR Price Date DR Price USD US / Non-US / Total DRs US / Non-US / Total DR Capital Raised USD
Aug 14, 2007 14.00 15,167,326
0
15,167,326
212,342,564
0
212,342,564
DR Symbol WX
CUSIP 929352102
DR Exchange New York Stock Exchange
DR ISIN US9293521020
Ratio 1:8
Depositary JPMC (Sponsored)
Effective Date Aug 14, 2007
Local Exchange Not Traded
Country China
Industry Pharma. & Biotech.

Powered by Interactive Data Managed Solutions

Monthly DR Trading Summary

Month Month End
DR Close
Price
DR Trading Volume Avg Day DR
Trading
Volume
Apr. 13 19.07 7,701,554 350,071
Mar. 13 17.18 6,626,002 331,300
Feb. 13 16.34 3,748,814 197,306
Data provided by Interactive Data Corp.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to
"Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

© 2013 The Bank of New York Mellon Corporation. Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Quotes delayed at least 15 minutes.Market data provided by Interactive Data
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

Certain information included in this website is proprietary to Mergent, Inc. (Mergent) Copyright © 2003-2010. Reproduction of such information in any form is prohibited. Because of the possibility of
human or mechanical error by Mergent's sources, Mergent or others, Mergent does not guarantee the accuracy, adequacy, completeness, timeliness or availability or for the results obtained from the
use of such information. Mergent Terms of Use apply

Holdings information provided by FactSet Research Systems Inc. Copyright © 2003-2013 FactSet Research Systems Inc. All rights reserved.

DR Calendar provided by Thomson Reuters, Inc. © 2013 The Thomson Reuters Corporation. All Rights Reserved. Terms of Use. Privacy Statement.
Send questions, comments or suggestions to corporateservices@thomsonreuters.com